Lorcaserin for weight management

Código QR

Lorcaserin for weight management

James R Taylor, Eric Dietrich, Jason PowellUniversity of Florida College of Pharmacy, Department of Pharmacotherapy and Translational Research, Gainesville, FL, USAAbstract: Type 2 diabetes and obesity commonly occur together. Obesity contributes to insulin resistance, a main cause of type 2 diabete...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Taylor JR, Dietrich E, Powell J
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2013
Materias:	Specialties of internal medicine RC581-951
Acceso en línea:	https://doaj.org/article/e230bb5d652f4158bc3432b2157a6039
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Challenging obesity, diabetes, and addiction: the potential of lorcaserin extended release
por: Hurt RT, et al.
Publicado: (2018)

Optimal management of type 2 diabetes in patients with increased risk of hypoglycemia
por: Anderson M, et al.
Publicado: (2014)

Assessing the effect of weight and weight loss in obese persons with type 2 diabetes
por: Bradley Curtis, et al.
Publicado: (2008)

Imaging body composition in obesity and weight loss: challenges and opportunities
por: Heidi J Silver, et al.
Publicado: (2010)

Perception of weight and psychological variables in a sample of Spanish adolescents
por: J&aacute;uregui-Lobera I, et al.
Publicado: (2011)

Optimizing weight control in diabetes: antidiabetic drug selection
por: S Kalra, et al.
Publicado: (2010)

Effect of weight loss on adipokine levels in obese patients
por: Hession M, et al.
Publicado: (2011)

Cardiometabolic results from an armband-based weight loss trial
por: Sieverdes JC, et al.
Publicado: (2011)

Predictors of weight loss and maintenance in patients treated with antiobesity drugs
por: Guaraldi F, et al.
Publicado: (2011)

Tackling obesity: new therapeutic agents for assisted weight loss
por: JG Karam, et al.
Publicado: (2010)

Salivary glucose concentration exhibits threshold kinetics in normal-weight, overweight, and obese children
por: Hartman ML, et al.
Publicado: (2014)

Effects of a leucine and pyridoxine-containing nutraceutical on body weight and composition in obese subjects
por: Zemel MB, et al.
Publicado: (2013)

Interventions to improve long-term weight loss in patients following bariatric surgery: challenges and solutions
por: McGrice M, et al.
Publicado: (2015)

PEARLS Randomized Lifestyle Trial in Pregnant Hispanic Women with Overweight/Obesity: Gestational Weight Gain and Offspring Birthweight [Corrigendum]
por: Trak-Fellermeier MA, et al.
Publicado: (2020)

Management of adult diabetic ketoacidosis
por: Gosmanov AR, et al.
Publicado: (2014)

Update on the management of diabetic polyneuropathies
por: Shakher J, et al.
Publicado: (2011)

Pharmacology, efficacy and safety of liraglutide in the management of type 2 diabetes
por: Joshua J Neumiller, et al.
Publicado: (2010)

Smartphone applications to aid weight loss and management: current perspectives
por: Sutton EF, et al.
Publicado: (2016)

Weight loss for women with and without polycystic ovary syndrome following a very low-calorie diet in a community-based setting with trained facilitators for 12 weeks
por: Nikokavoura EA, et al.
Publicado: (2015)

The effects of diet- and diet plus exercise-induced weight loss on basal metabolic rate and acylated ghrelin in grade 1 obese subjects
por: Lopes AL, et al.
Publicado: (2013)

Combination of the sodium-glucose cotransporter-2 inhibitor empagliflozin with orlistat or sibutramine further improves the body-weight reduction and glucose homeostasis of obese rats fed a cafeteria diet
por: Vickers SP, et al.
Publicado: (2014)

Using a technology-based intervention to promote weight loss in sedentary overweight or obese adults: a randomized controlled trial study design
por: Vaughn W Barry, et al.
Publicado: (2011)

Management of gestational diabetes mellitus
por: Annunziata Lapolla, et al.
Publicado: (2009)

Management of adult diabetic ketoacidosis
por: Rosival V
Publicado: (2014)

Insulin glulisine in the management of diabetes
por: Satoru Yamada
Publicado: (2009)

Management of obesity and cardiometabolic risk – role of phentermine/extended release topiramate
por: Sweeting AN, et al.
Publicado: (2014)

Increasing effect of body weight perception on suicidal ideation among young Korean women: Findings from the Korea National Health and Nutrition Examination Survey 2001 and 2005
por: Dong-Sik Kim
Publicado: (2011)

Management of limited joint mobility in diabetic patients
por: Abate M, et al.
Publicado: (2013)

Type 2 diabetes in Brazil: epidemiology and management
por: Almeida-Pititto B, et al.
Publicado: (2015)

Current perspectives on the health risks associated with the consumption of advanced glycation end products: recommendations for dietary management
por: Palimeri S, et al.
Publicado: (2015)

Lifestyle modification in the management of the metabolic syndrome: achievements and challenges
por: Riccardo Dalle Grave, et al.
Publicado: (2010)

Nutritional therapy for the management of diabetic gastroparesis: clinical review
por: Sadiya A
Publicado: (2012)

Risk management in the treatment of type 2 diabetes with pioglitazone
por: Giuseppe Derosa, et al.
Publicado: (2009)

Managing diabetic patients with moderate or severe renal impairment using DPP-4 inhibitors: focus on vildagliptin
por: Russo E, et al.
Publicado: (2013)

Guidelines in the management of diabetic nerve pain clinical utility of pregabalin
por: Vinik AI, et al.
Publicado: (2013)

Fixed combination of repaglinide and metformin in the management of type 2 diabetes
por: Robert Moses
Publicado: (2009)

Role and development of GLP-1 receptor agonists in the management of diabetes
por: Chee&nbsp;W Chia, et al.
Publicado: (2009)

Management of diabetes across the course of disease: minimizing obesity-associated complications
por: Apovian CM
Publicado: (2011)

The role of lipid and carbohydrate digestive enzyme inhibitors in the management of obesity: a review of current and emerging therapeutic agents
por: Sonia A Tucci, et al.
Publicado: (2010)

Sotagliflozin improves glycemic control in nonobese diabetes-prone mice with type 1 diabetes
por: Powell DR, et al.
Publicado: (2015)